Idenix Pharmaceuticals News

New York, NY -- XOMA Ltd. ; Biostar Pharmaceuticals, Inc. ; Idenix Pharmaceuticals, Inc.

Idenix Pharmaceuticals, Inc. , a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced presentations of data on IDX184, a once-daily novel liver-targeted nucleotide prodrug of 2'-methyl guanosine for the treatment of HCV, at the annual meeting of the American ...

Idenix Pharmaceuticals, Inc. , a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced that two abstracts on IDX184, the company's lead hepatitis C development program, have been accepted for presentation at the 60th Annual Meeting of the American Association for the ...

Idenix Pharmaceuticals is trading 0.3% lower today on volume of 80,589 shares. The stock has traded within a 52-week range of $1.86 and $7.83. Idenix Pharmaceuticals is currently below its 50-day moving average of $3.32 and below its 200-day moving average of $4.01. SmarTrend is bearish on shares of IDIX and our subscribers received a Downtrend ...

Drug maker Idenix Pharmaceuticals Inc. said it plans to net $21.2 million from a common stock offering underwritten by Boston-based investment bank Leerink Swann LLC.

Shares of Idenix Pharmaceuticals Inc. plunged Tuesday after the biotechnology company reported a wider-than-expected second-quarter loss and one analyst said financing issues could weaken its position in partnership discussions.

JDA Software Group, Inc. And Apple Inc. Is Expected To See Active Trading In Today's Market Dallas, TX - LiquidTycoon.com is pleased to alert investors of stocks on the move.